ASHLEY DAVIOS: Open Payments
NPI 1104583103 · ROSLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 16 payments from 8 companies in 2025. Trend: 2023 $153 · 2024 $234 · 2025 $635
Food & beverage: $635
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $418 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| Amgen Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Philips North America LLC | 1 | $28 |
| Recor Medical Inc | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: Wegovy, LEQVIO, FARXIGA, MCOT, Paradise Ultrasound Renal Denervation System, Kerendia, Ozempic, Rybelsus.
Industry payments across NY — which companies pay providers there.
